What is the current price and market cap of 2228.HK stock?

Pre-market on 14 Feb 2026, 2228.HK stock is **HK$11.21** with market cap **HK$48,025,628,853**. Volume today reached **46,409,868** shares versus an average volume of **73,689,149**.

What is Meyka AI’s forecast and rating for 2228.HK stock?

Meyka AI's forecast model projects a monthly target of **HK$14.10** and rates 2228.HK **63.04 (Grade B)** with a **HOLD** suggestion. These are model outputs and not investment guarantees.

What are the main risks for investors in 2228.HK stock?

Key risks include long receivables (DSO **268.35** days), negative margins (**-28.90%** net margin), high price-to-sales (**62.25**), and execution risk scaling AI services across markets.

When is XtalPi’s next earnings release and how should traders use it?

XtalPi’s earnings announcement is scheduled for **27 Mar 2026**. Traders should watch revenue guidance, AI partnership updates and cash flow metrics and use confirmed volume as a signal before adding exposure.

HK Stocks

HK$11.21 XtalPi (2228.HK) Pre-Market: AI drug discovery growth meets valuation gap

ByDanny Kontos February 13, 2026February 13, 2026

The 2228.HK stock trades at HK$11.21 in Hong Kong pre-market on 14 Feb 2026, down 1.41% from the previous close. Volume has run to 46,409,868 shares against a 50-day average of 10.99 HKD, showing strong interest in XtalPi Holdings Ltd (2228.HK) amid renewed investor focus on AI drug discovery. We look at technicals, fundamentals, Meyka AI forecasts and a realistic price target for traders and investors.